DOSI PHARMA SL
Company details
- Active NIF/CIF: B65282220
-
-
-
-
Address: POLIGONO INDUSTRIAL EL PONT (C/ C), NAVE, 4,08254,El Pont De Vilomara I Rocafort,Barcelona,Spain
-
-
Featured products:
More information on DOSI PHARMA SL
-
21/03/2016 | BORME act no.: 128135 | Register: BARCELONARevocaciones
-
21/03/2016 | BORME act no.: 128135 | Register: BARCELONANombramientos
-
04/12/2012 | BORME act no.: 499128 | Register: BARCELONARevocaciones
-
04/12/2012 | BORME act no.: 499128 | Register: BARCELONANombramientos
-
04/12/2012 | BORME act no.: 499128 | Register: BARCELONAModificaciones estatutarias
-
13/03/2012 | BORME act no.: 119282 | Register: BARCELONAModificaciones estatutarias
-
14/05/2010 | BORME act no.: 193861 | Register: BARCELONAConstitución
-
14/05/2010 | BORME act no.: 193861 | Register: BARCELONANombramientos
Other information
The CIF of DOSI PHARMA SL is B65282220 and its current business status is active. Its economic sector is within the CNAE 4646 - Comercio al por mayor de productos farmacéuticos. Its SIC classification is 5122 - Droguería, perfumería y farmacia.
DOSI PHARMA SL employs approximately Between 10 and 49 employees and generates an annual turnover of less than 2 million euros. The company is registered in the Mercantile Registry of Barcelona. To date, it has 4 registration charges. Its most recent announcement in the Borme was published on 21/03/2016 and its last deposit of ordinary annual accounts corresponds to the year -.
You can access the contact information of DOSI PHARMA SL, such as the telephone number, postal address, and website, in the Company Data section.
If you wish to obtain more information about DOSI PHARMA SL, you can review one of our available financial reports, the Annual Accounts of the company, or check if it has any registered payment incidents in the RAI delinquency file.
The financial, commercial, and legal information of DOSI PHARMA SL comes from official data sources and is automatically updated every day.
Do you want to know more about DOSI PHARMA SL??
Find out more about this company by consulting these reports: